Buckingham Strategic Partners Medicinova Inc Transaction History
Buckingham Strategic Partners
- $4.37 Billion
- Q3 2024
A detailed history of Buckingham Strategic Partners transactions in Medicinova Inc stock. As of the latest transaction made, Buckingham Strategic Partners holds 10,000 shares of MNOV stock, worth $21,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$21,300% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding MNOV
# of Institutions
31Shares Held
4.83MCall Options Held
9.4KPut Options Held
6K-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$2.36 Million0.67% of portfolio
-
Black Rock Inc. New York, NY695KShares$1.48 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA623KShares$1.33 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA506KShares$1.08 Million0.0% of portfolio
-
Citigroup Inc448KShares$954,1480.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $104M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...